Hangzhou Elemental Pharmaceutical

Hangzhou Elemental Pharmaceutical is an innovative pharmaceutical company based in Hangzhou, China, that focuses on the development, commercialization, and contract manufacturing of high-quality finished drugs. Founded in 2018 as a wholly-owned subsidiary of Baihui Holdings (Hong Kong) Limited, the company primarily targets the respiratory health and male sexual health therapeutic areas. Its commercial portfolio includes approved products such as Ambroxol Hydrochloride Oral Solution (marketed under the brand name Yuansu Antan) for respiratory conditions and Tadalafil Tablets for erectile dysfunction. Operating under China's Marketing Authorization Holder (MAH) system, the company strategically outsources its manufacturing to regional partners like Zhejiang Kairun Pharmaceutical while maintaining strict internal quality control and regulatory oversight. Hangzhou Elemental Pharmaceutical leverages the robust life sciences ecosystem of the Yangtze River Delta to expand its market presence in domestic high-end finished formulations.